Cipher Pharmaceuticals Inc
TSX:CPH

Watchlist Manager
Cipher Pharmaceuticals Inc Logo
Cipher Pharmaceuticals Inc
TSX:CPH
Watchlist
Price: 11.91 CAD 0.85%
Market Cap: 305m CAD

Intrinsic Value

The intrinsic value of one CPH stock under the Base Case scenario is 10.42 CAD. Compared to the current market price of 11.91 CAD, Cipher Pharmaceuticals Inc is Overvalued by 13%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CPH Intrinsic Value
10.42 CAD
Overvaluation 13%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Cipher Pharmaceuticals Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
CPH
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for CPH cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Cipher Pharmaceuticals Inc
TSX:CPH
CA
Pharmaceuticals
Market Cap
304.9m CAD
IPO
Feb 25, 2004
CA
Pharmaceuticals
Market Cap
304.9m CAD
IPO
Feb 25, 2004
Price
CA$false
EPS
$false
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CPH?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Cipher Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cipher Pharmaceuticals Inc

Current Assets 38.5m
Cash & Short-Term Investments 17.8m
Receivables 13.9m
Other Current Assets 6.8m
Non-Current Assets 124m
PP&E 680k
Intangibles 96.2m
Other Non-Current Assets 27.1m
Efficiency

Free Cash Flow Analysis
Cipher Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cipher Pharmaceuticals Inc

Revenue
33.4m USD
Cost of Revenue
-9.3m USD
Gross Profit
24.1m USD
Operating Expenses
-16.3m USD
Operating Income
7.8m USD
Other Expenses
3.7m USD
Net Income
11.5m USD
Fundamental Scores

CPH Profitability Score
Profitability Due Diligence

Cipher Pharmaceuticals Inc's profitability score is 77/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Gross Profit
Exceptional 3-Year Average ROE
Negative Free Cash Flow
77/100
Profitability
Score

Cipher Pharmaceuticals Inc's profitability score is 77/100. The higher the profitability score, the more profitable the company is.

CPH Solvency Score
Solvency Due Diligence

Cipher Pharmaceuticals Inc's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
68/100
Solvency
Score

Cipher Pharmaceuticals Inc's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CPH Price Targets Summary
Cipher Pharmaceuticals Inc

Wall Street analysts forecast CPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CPH is 19.15 CAD with a low forecast of 14.65 CAD and a high forecast of 26.25 CAD.

Lowest
Price Target
14.65 CAD
23% Upside
Average
Price Target
19.15 CAD
61% Upside
Highest
Price Target
26.25 CAD
120% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Cipher Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CPH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one CPH stock?

The intrinsic value of one CPH stock under the Base Case scenario is 10.42 CAD.

Is CPH stock undervalued or overvalued?

Compared to the current market price of 11.91 CAD, Cipher Pharmaceuticals Inc is Overvalued by 13%.

Back to Top